Am Fam Physician. 2006;73(10):1704
The article “Preventive Counseling, Screening, and Therapy for the Patient with Newly Diagnosed HIV Infection” (January 15, 2006, page 271) contained an error in the last recommendation of the “SORT: Key Recommendations for Practice” table regarding the CD4+ cell counts at which antibiotic prophylaxis for toxoplasmosis and Mycobacterium avium-intracellulare complex should be initiated (the cutoffs were inadvertently transposed). The recommendation should have read as follows: “Antibiotic prophylaxis should be used to prevent toxoplasmosis and Mycobacterium avium-intracellulare complex infection at CD4+ cell counts below 100 and below 50 cells per mm3, respectively.” The online version of this article has been corrected and the corrected SORT table appears below.
| Clinical recommendation | Evidence rating | References |
|---|---|---|
| Patients with HIV should be monitored for CD4+ lymphocyte and HIV RNA levels every three to six months. | C | 7, 8, 26, 28 |
| Patients who are hepatitis A or B nonimmune at baseline should be vaccinated. | B | 7, 8, 25 |
| Tuberculosis prophylaxis should be given to patients with any of the following: history or symptoms of tuberculosis, a PPD of at least 5 mm, or a possible false-negative PPD. | C | 7, 8, 25 |
| Pneumocystis jiroveci prophylaxis with trimethoprim/sulfamethoxazole (Bactrim, Septra) should be initiated at CD4+ counts of less than 200 cells per mm3. | A | 7, 8, 25 |
| Women with HIV should have Pap smears every six months for the first year and, if normal, annual Pap smears thereafter. | C | 7, 8, 25 |
| High-risk patients with ongoing exposure should be checked annually for gonorrhea, chlamydia, syphilis, and hepatitis C. | C | 7, 8, 25 |
| Antibiotic prophylaxis should be used to prevent toxoplasmosis and Mycobacterium avium-intracellulare complex infection at CD4+ cell counts below 100 and below 50 cells per mm3, respectively. | B | 7, 8, 25 |